Authors: de Picciotto, J Friedland, D

Citation: J. De Picciotto et D. Friedland, Verbal fluency in elderly bilingual speakers: Normative data and preliminary application to Alzheimer's disease, FOLIA PHON, 53(3), 2001, pp. 145-152

Authors: Fliegelman, LJ Friedland, D Brandwein, M Rothschild, M

Citation: Lj. Fliegelman et al., Lymphatic malformation: Predictive factors for recurrence, OTO H N SUR, 123(6), 2000, pp. 706-710

Authors: Stevenson, JP Yao, KS Gallagher, M Friedland, D Mitchell, EP Cassella, A Monia, B Kwoh, TJ Yu, R Holmlund, J Dorr, FA O'Dwyer, PJ

Citation: Jp. Stevenson et al., Phase I clinical pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A), J CL ONCOL, 17(7), 1999, pp. 2227-2236

Authors: Friedland, D

Citation: D. Friedland, Conversation as an achievement in aphasics, CLIN LING P, 13(1), 1999, pp. 74-75

Authors: Friedland, D Miller, N

Citation: D. Friedland et N. Miller, Language mixing in bilingual speakers with Alzheimer's dementia: a conversation analysis approach, APHASIOLOGY, 13(4-5), 1999, pp. 427-444

Authors: Friedland, D Cohen, J Miller, R Voloshin, M Gluckman, R Lembersky, B Zidar, B Keating, M Reilly, N Dimitt, B

Citation: D. Friedland et al., A phase II trial of docetaxel (Taxotere) in hormone-refractory prostate cancer: Correlation of antitumor effect to phosphorylation of Bcl-2, SEMIN ONCOL, 26(5), 1999, pp. 19-23